Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 - Mao, Long; Shaabani, Namir; Zhang, Xiaoying; Jin, Can; Xu, Wanhong; Argent, Christopher; Kushnareva, Yulia; Powers, Colin; Stegman, Karen; Liu, Jia; Xie, Hui; Xu, Changxu; et al. (Med (New York, N.Y. : Online), 2024)